BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16046580)

  • 1. Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque.
    Fraser HM; Wilson H; Morris KD; Swanston I; Wiegand SJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5811-8. PubMed ID: 16046580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single injections of vascular endothelial growth factor trap block ovulation in the macaque and produce a prolonged, dose-related suppression of ovarian function.
    Fraser HM; Wilson H; Rudge JS; Wiegand SJ
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1114-22. PubMed ID: 15562010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).
    Wulff C; Wilson H; Rudge JS; Wiegand SJ; Lunn SF; Fraser HM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3377-86. PubMed ID: 11443214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor.
    Fraser HM; Dickson SE; Lunn SF; Wulff C; Morris KD; Carroll VA; Bicknell R
    Endocrinology; 2000 Mar; 141(3):995-1000. PubMed ID: 10698175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey.
    Zimmermann RC; Xiao E; Bohlen P; Ferin M
    Endocrinology; 2002 Jul; 143(7):2496-502. PubMed ID: 12072380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys.
    Hazzard TM; Xu F; Stouffer RL
    Biol Reprod; 2002 Oct; 67(4):1305-12. PubMed ID: 12297549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset.
    Taylor PD; Wilson H; Hillier SG; Wiegand SJ; Fraser HM
    Mol Hum Reprod; 2007 Oct; 13(10):729-36. PubMed ID: 17804434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset.
    Fraser HM; Wilson H; Wulff C; Rudge JS; Wiegand SJ
    Reproduction; 2006 Oct; 132(4):589-600. PubMed ID: 17008470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles.
    Lenton EA; de Kretser DM; Woodward AJ; Robertson DM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1180-90. PubMed ID: 1955499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey.
    Zimmermann RC; Xiao E; Husami N; Sauer MV; Lobo R; Kitajewski J; Ferin M
    J Clin Endocrinol Metab; 2001 Feb; 86(2):768-72. PubMed ID: 11158044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between gonadotrophins, inhibin and sex steroid secretion during the periovulatory period and the luteal phase in the blue fox (Alopex lagopus).
    Mondain-Monval M; Farstad W; Smith AJ; Roger M; Lahlou N
    J Reprod Fertil Suppl; 1993; 47():47-56. PubMed ID: 8229964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
    Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
    Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and contribution of the HIF-1α/VEGF signaling pathway to luteal development and function in pregnant rats.
    Wu L; Zhang Z; Pan X; Wang Z
    Mol Med Rep; 2015 Nov; 12(5):7153-9. PubMed ID: 26323652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.